Frank Yocca Bio Xcel Therapeutics, Inc. (BTAI) insider trading activity

BTAI Quotes by TradingView

Frank Yocca is Chief Scientific Officer of BioXcel Therapeutics, Inc.. Currently has a direct ownership of 6,384 shares of BTAI, which is worth approximately $17,236. The most recent transaction as insider was on Mar 14, 2023, when has been sold 2,084 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.38K
228.9% 3M change
77.42% 12M change
Total Value Held $17,236

Frank Yocca Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 14 2023
BUY
Exercise of conversion of derivative security
-
2,084 Added 16.59%
10,481 Common Stock
Jan 20 2023
SELL
Open market or private sale
$1,500,000 $30.0 p/Share
50,000 Reduced 85.62%
8,397 Common Stock
Mar 15 2021
SELL
Open market or private sale
$733,350 $48.89 p/Share
15,000 Reduced 20.44%
58,397 Common Stock
Feb 16 2021
SELL
Open market or private sale
$877,950 $58.53 p/Share
15,000 Reduced 16.97%
73,397 Common Stock
Jan 25 2021
SELL
Open market or private sale
$721,050 $48.07 p/Share
15,000 Reduced 14.51%
88,397 Common Stock
Jan 25 2021
BUY
Exercise of conversion of derivative security
$6,150 $0.41 p/Share
15,000 Added 12.67%
103,397 Common Stock
FY

Frank Yocca

Chief Scientific Officer
New Haven, CT

Track Institutional and Insider Activities on BTAI

Follow BioXcel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BTAI shares.

Notify only if

Insider Trading

Get notified when an Bio Xcel Therapeutics, Inc. insider buys or sells BTAI shares.

Notify only if

News

Receive news related to BioXcel Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BTAI